Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
-20.58%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
-0.06%
median of 853 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
GT Biopharma, Inc.
Market Cap
$8.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.16M
Net Profit Margin
N/A
TTM Avg
-206582.99%
3Y Avg
-143015.53%
5Y Avg
-102538.66%
Market Cap
$7.92M
Net Profit Margin
0.00%
TTM Avg
-431.21%
3Y Avg
-828.00%
5Y Avg
-552.00%
Market Cap
$7.92M
Net Profit Margin
328.67%
TTM Avg
-11931.69%
3Y Avg
-10159.65%
5Y Avg
-9780.14%
Market Cap
$7.89M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.28M
Net Profit Margin
-66.29%
TTM Avg
-59.63%
3Y Avg
-44.17%
5Y Avg
-31.01%
Market Cap
$7.79M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.73M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.50M
Net Profit Margin
-1100.30%
TTM Avg
-235.88%
3Y Avg
-120.03%
5Y Avg
-120.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $8.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartSciences Inc. (HSCS)vs › | $8.16M | N/A | -206582.99% | -143015.53% | -102538.66% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.92M | 0.00% | -431.21% | -828.00% | -552.00% |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | 328.67% | -11931.69% | -10159.65% | -9780.14% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.28M | -66.29% | -59.63% | -44.17% | -31.01% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.73M | 0.00% | 0.00% | 0.00% | 0.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.50M | -1100.30% | -235.88% | -120.03% | -120.03% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.25M | -0.61% | -82.77% | -131.16% | -372.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | -56400.00% |
| 2015-06-30 | 134300.00% |
| 2015-03-31 | -293085.71% |
| 2014-12-31 | -56472.73% |
| 2014-09-30 | -140666.67% |
| 2014-06-30 | -1048.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -863.41% |
| 2013-09-30 | -174.32% |
| 2013-06-30 | -546.43% |
| 2013-03-31 | 531.82% |
| 2012-12-31 | -347.49% |
| 2012-09-30 | -1166.67% |
| 2012-06-30 | -239500.00% |
| 2012-03-31 | -61500.00% |
| 2011-12-31 | -37933.33% |
| 2011-09-30 | 1150.00% |
| 2011-06-30 | -66200.00% |
| 2011-03-31 | -9615.00% |
| 2010-12-31 | -6018.18% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | -10284.62% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | -1014.29% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 26.73% |
| 2008-09-30 | -253.02% |
| 2008-06-30 | -171.61% |
| 2008-03-31 | -71.60% |
| 2007-12-31 | 21.15% |
| 2007-09-30 | -7.89% |
| 2007-06-30 | 59.85% |
| 2007-03-31 | -55.64% |
| 2006-12-31 | -216.34% |
| 2006-09-30 | -43.19% |
| 2006-06-30 | -42.70% |
| 2006-03-31 | -45.60% |
| 2005-12-31 | -287.80% |
| 2005-09-30 | -59.77% |
| 2005-06-30 | -54.05% |
| 2005-03-31 | -39.46% |
| 2004-12-31 | -199.27% |
| 2004-09-30 | -5.56% |
| 2004-06-30 | -275.52% |
| 2004-03-31 | -104.59% |
| 2003-12-31 | -22.68% |
| 2003-09-30 | -25.71% |
| 2003-06-30 | -42.06% |
| 2003-03-31 | -27.14% |
| 2002-12-31 | -34.74% |
| 2002-09-30 | -69.95% |
